Iridex (IRIX) Invested Capital (2020 - 2021)

Iridex's (IRIX) quarterly Invested Capital came in at $2.2 million in Q2 2021, up 74.94% quarter-over-quarter from $1.2 million in Q1 2021.

Iridex (IRIX) Invested Capital (2020 - 2021) Analysis & Trends

Iridex's Invested Capital history runs 2 years deep, the most recent figure standing at $2.2 million for Q2 2021.

On a quarterly basis, Invested Capital changed N/A year-over-year to $2.2 million in Q2 2021; TTM through Jan 2022 was $2.2 million, a 21.26% decrease from a year earlier, with the FY2021 full-year figure at $1.2 million, changed N/A from the prior year.
Invested Capital improved to $2.2 million in Q2 2021 per IRIX's latest filing, from $1.2 million in the prior quarter.
Across five years, Invested Capital topped out at $2.2 million in Q2 2021 and bottomed at $1.2 million in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	4.41 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	499.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	41.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	1.41 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	7.00 Mn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	15.00 Mn
10	Iridex	15.93 Mn	11.33 Mn	4.74 Mn	-

Download Data